Studies suggest that the two primary symptoms associated with contact lens-related dry eye are itching and discomfort. Patient self-perception of dry eye during contact lens wear suggests that folks over the age of 40 think their eyes feel dry and too often ache when they wear contacts. This leads to discontinuation of lens wear.

One study found that after only five years of lens wear, approximately 12 percent of contact lens patients permanently discontinue contact lens wear primarily due to discomfort and dryness. This percentage goes up as the years go on. Contact lens manufacturers report that the number of people who wear contact lenses stays virtually the same. Almost the same number of older people quit wearing contact lens every year because of dryness and discomfort as the number of younger people begin to wear them.

This should not happen to people who love wearing their contact lenses.

Patients will usually tell their eye care professional how their eyes feel (if they ask) before they completely give up their contacts. Can you imagine how many people would continue to wear contacts if they were more comfortable? If eye doctors could do a better job of managing these eventual contact lens-related dry eye patients when they fit them for their first lenses, they might not disappear from their, and probably a few other doc’s, appointment books.

One way to add to the years of comfortable contact lenses wear is to systemically address all three layers of the tear film with specific nutrients.

The goblet cell and mucin base layer is somewhat vitamin A and vitamin D dependent, the water layer is dependent on the nutrients and the nutrient co-factors that address inflammation control and stimulate the ocular surface/brain/lacrimal gland neuronal loop. Meibomian gland output is dependent on fatty acids and the nutrient co-factors that stimulate fatty acid metabolism.

Neither Omega-3 fish oil nor flax seed oil alone can adequately address the delicate biochemistry of all three tear film layers .

BioTears is a patented formulation designed to systemically address the root inflammatory cause and effects of dry eye syndrome. It’s suggested in peer-reviewed literature that these specific nutrients support normal production of lubricants in other affected parts of the body, such as mucous membranes of the mouth and vagina, and interior body surfaces such as joints and synovial membranes.

BioTears addresses the structure and function of the tear film, which is vital for visual clarity.

BioTears contain the optimal blend of Omega 3 and Omega 6 essentials fatty acids, plus all the nutrient co-factors suggested to enhance the metabolic conversion associated with the tear-specific series one anti-inflammatory prostaglandin, PGE1.

BioTears include nutrients that are suggested to appropriately inhibit the essential fatty acid arachidonic acid production of the COX2 enzyme, the pro-inflammatory prostaglandin PGE2, and Interleukin Il-6.

BioTears include nutrients that are suggested to modulate goblet cell/mucin production in both the stimulated and unstimulated tears, the lacrimal gland aqueous output, as well as the meibomian gland oil output, which is vital to the prevention of evaporative dry eyes.

BioTears also contain APO-Lactoferrin, which is suggested to inhibit the growth of both viral and bacterial pathogens in the three-layer tear film. This is particularly important for the contact lens wearer.

Ellen Troyer, MT MA –

Biosyntrx Chief Research Officer